Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes.
Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes.
复制标题
DOI:
10.1002/dmrr.2316
复制
发表时间:
2012-10
影响因子:
8
通讯作者:
Atkinson, Mark
中科院分区:
文献类型:
--
作者:
Campbell-Thompson, Martha;Wasserfall, Clive;Kaddis, John;Albanese-O'Neill, Anastasia;Staeva, Teodora;Nierras, Concepcion;Moraski, Jayne;Rowe, Patrick;Gianani, Roberto;Eisenbarth, George;Crawford, James;Schatz, Desmond;Pugliese, Alberto;Atkinson, Mark
The Network for Pancreatic Organ donors with Diabetes was established to recover and characterize pancreata and related organs from cadaveric organ donors with various risk levels for type 1 diabetes (T1D). These biospecimens are available to investigators for collaborative studies aimed at addressing questions related to TID natural history and pathogenesis. Organ donors included T1D patients (new-onset to long-term), non-diabetic autoantibody positive subjects, non-diabetic controls, and individuals with disorders relevant to β-cell function. Pancreas recovery and transport met transplant-grade criteria. Additional samples recovered included serum, whole blood, spleen, and pancreatic and non-pancreatic lymph nodes. Biospecimens were processed for cryopreserved cells, fixed paraffin and fresh frozen blocks, and snap frozen samples. T1D autoantibodies, c-peptide levels, and high-resolution HLA genotyping for risk alleles were also determined. Over 160 donors have been enrolled (ages of 1 day to > 90 years). Standard operating procedures were established along with a quality management system. Donor demographics, laboratory assays, and histopathological characterizations were shared through an open online informatics system. Biospecimens were distributed to more than 60 investigators. The nPOD program provides access to high quality biospecimens without cost to investigators. Collaborations and open data sharing are emphasized to maximize research potential of each donor. Based on initial successes, the nPOD program is expanding to recover additional organs relevant to T1D pathogenesis and complications from European countries (PanFin network).
登录
查看更多内容
影响因子:
7.7
作者:
Keenan HA;Sun JK;Levine J;Doria A;Aiello LP;Eisenbarth G;Bonner-Weir S;King GL
通讯作者:
King GL
影响因子:
30.5
作者:
通讯作者:
--
影响因子:
12.8
作者:
Maniatis, AK;Yu, LP;Eisenbarth, GS
通讯作者:
Eisenbarth, GS
影响因子:
16.2
作者:
Orban T;Sosenko JM;Cuthbertson D;Krischer JP;Skyler JS;Jackson R;Yu L;Palmer JP;Schatz D;Eisenbarth G;Diabetes Prevention Trial-Type 1 Study Group
通讯作者:
Diabetes Prevention Trial-Type 1 Study Group
影响因子:
7.7
作者:
In't Veld, Peter;Lievens, Dirk;Pipeleers, Daniel
通讯作者:
Pipeleers, Daniel